Incyte Corporation

Incyte Genomics, Inc.

Bridget A Warren

Mariah R Baughn

Y Tom Tang

Henry Yue

April J A Hafalia

Dyung Aina M Lu

Ameena R Gandhi

Monique G Yao

Yan Lu

Neil Burford

Li Ding

Olga Bandman

Preeti G Lal

Craig H Ison

Junming Yang

Brendan M Duggan

Anita Swarnakar

Yuming Xu

Bao M Tran

Sally Lee

Kimberly J Gietzen

Madhusudan M Sanjanwala

Cynthia D Honchell

Michael Thorton

Vicki S Elliott

Narinder K Chawla

Narinder K Walia

Kavitha Thangavelu

Stephanie Kareht

Kavitha Thangaveln

Janice K Au-Young

Chandra S Arvizu

Danniel B Nguyen

Rajagopal Gururajan

Catherine M Tribouley

Jayalaxmi Ramkumar

Stephanie K Sapperstein

Liam Kearney

Vicki S Kaulback

Ernestine A Lee

Yalda Azimzai

Angelo M Delegeane

Roopa M Reddy

Michael B Thornton

Gregory Marcus

Farrah A Khan

Jennifer L Policky

Randi E Krasnow

Debopriya Das

John D Burrill

Kurt A Zingler

Preeti G Lai

Vicki S Elliott Kaulback

Stephen Todd

Deborah A Kallick

Mark L Borowsky

Roberto Hernandez

Amy K Wolven

The invention provides human secreted proteins (SECP) and polynucleotides which identify and encode SECP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SECP.

Secreted proteins

Antibody to secreted polypeptide

The invention provides human human kinases (PKIN) and polynucleotides which identify and encode PKIN. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PKIN.

Human cAMP-dependent protein kinase beta-catalytic subunit

The invention provides a human cysteine proteases and polynucleotides which encode those proteases. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists, as well as methods for diagnosing, treating, or preventing disorders associated with aberrant expression of cysteine proteases.

Proteases

The invention provides a cDNA which encodes a colon cancer marker. It also provides for the use of the cDNA, fragments, complements, and variants thereof and of the encoded protein, portions thereof and antibodies thereto for diagnosis and treatment of colon disorders, particularly colon cancer and polyps. The invention additionally provides expression vectors and host cells for the production of the protein and a transgenic model system.

Colon cancer marker

Growing community of inventors

Encinitas, CA, United States of America

Bridget A Warren